Market Overview:
The global infertility diagnosis market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The market growth is attributed to the increasing incidence of infertility, rising awareness about fertility treatments, and technological advancements in the field of infertility diagnosis. The global infertility diagnosis market is segmented by type into female infertility testing and male infertility testing. Female Infertility Testing dominates the market with a share of more than 60%. This can be attributed to the high prevalence rate of female infertility across the globe. Male Infertility Testing is expected to grow at a higher CAGR during the forecast period as there has been an increase in awareness about male-factor infertility in recent years. The global fertility diagnostics market is segmented by application into hospitals, clinics, fertility centers, research institutes, and other applications such as home use and point-of-care (POC) testing. Hospitals account for majority share in terms of revenue followed by clinics due to increasing number of patients seeking treatment for various types of fertility disorders in these settings worldwide . Fertility centers are expected to witness highest growth during the forecast period owing to growing demand for assisted reproductive technologies (ARTs) globally . Research institutes are also anticipated witness significant growth during 2018–2030 due primarily increased R&D investments towards development new diagnostic tests/technologies for detection & characterization ovarian reserve & oocyte quality .
Product Definition:
A diagnosis of infertility is made when a couple has not been able to conceive after one year of unprotected intercourse. The diagnosis is important because it allows couples to seek treatment and hopefully conceive.
Female Infertility Testing:
Female infertility is the inability of a female to carry out normal pregnancy. It can be due to a number of reasons, one such reason being stress. There are various tests that are conducted for diagnosing female infertility, the most common ones being an ultrasound scan and blood test known as Fertility Analysis or Ovulation Detection Test (OCT). Other tests include endometrial biopsy, laparoscopy & cystoscopy and an MRI scan of the pelvis.
Male Infertility Testing:
Male infertility is the inability of a man to produce sperm which results in the absence of sperms. There are various factors that can cause male infertility such as infections, drugs, trauma and certain genetic disorders. The most common type of male infertility is caused due to a blockage in the vas deferens (the tube that carries sperms from the testicles).
Application Insights:
Based on application, the global infertility diagnosis market is segmented into hospitals, clinics, fertility centers and research institutes. Hospitals held the largest share in 2017 owing to factors such as availability of advanced diagnostics and treatment facilities at hospitals. Additionally, high prevalence of Infertility Diseases & Unmarried Women¢â‚¬â„¢s Syndrome (IWUS) at hospital-based clinics worldwide is expected to drive demand for diagnostic tests over the forecast period.
The fertility center segment is anticipated to witness significant growth over the forecast period due to increasing number of assisted reproductive technology (ART) procedures being performed there compared with hospitals. This includes IVF procedures as well as egg donation programs where eggs are retrieved from women through laparoscopy or hysteroscopy and then fertilized by sperm through ICSI or intracytoplasmic sperm injection (ICSI).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of fertility clinics and hospitals, increased adoption of advanced infertility treatments, rising awareness about available treatment options, and supportive government initiatives. For instance, in February 2016, egg freezing was added as a covered service under COBRA coverage which extended insurance coverage for women undergoing IVF procedures.
Asia Pacific is expected to grow at the fastest rate during the forecast period owing to an increase in demand for assisted reproductive technology (ART) treatment from countries such as China and India due to increasing infertility rates among people born before 1960s coupled with rising awareness about these services among young population groups.
Growth Factors:
- Increasing incidence of infertility: The infertility diagnosis market is expected to grow due to the increasing incidence of infertility. According to the World Health Organization, about 10-15% of couples around the world are affected by infertility. This number is expected to increase in the future due to various factors such as changing lifestyles, increased stress levels, and exposure to environmental toxins.
- Advances in technology: The market for fertility diagnostics is expected to grow due to advances in technology that have made it easier and more affordable for people to undergo fertility tests. For example, new technologies such as next-generation sequencing (NGS) are making it possible for doctors to diagnose causes of infertility with greater accuracy than ever before.
- Growing demand for assisted reproductive technologies (ART): The use of assisted reproductive technologies (ART) has been growing rapidly in recent years as more and more couples seek help in conceiving a child. This is driving demand for products and services relatedto ART, which will benefit the fertility diagnostics market growth rate over the forecast period .
Scope Of The Report
Report Attributes
Report Details
Report Title
Infertility Diagnosis Market Research Report
By Type
Female Infertility Testing, Male Infertility Testing
By Application
Hospitals, Clinics, Fertility Centers, Research Institutes, Other
By Companies
Merck, Procter & Gamble, BioMerieux, Abbott, Babystart, BioZhena Corporation, Quidel Corporation, SPD Swiss Precision Diagnostics GmbH, SCSA Diagnostics, Pride Angel
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
120
Number of Tables & Figures
84
Customization Available
Yes, the report can be customized as per your need.
Global Infertility Diagnosis Market Report Segments:
The global Infertility Diagnosis market is segmented on the basis of:
Types
Female Infertility Testing, Male Infertility Testing
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Fertility Centers, Research Institutes, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Merck
- Procter & Gamble
- BioMerieux
- Abbott
- Babystart
- BioZhena Corporation
- Quidel Corporation
- SPD Swiss Precision Diagnostics GmbH
- SCSA Diagnostics
- Pride Angel
Highlights of The Infertility Diagnosis Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Female Infertility Testing
- Male Infertility Testing
- By Application:
- Hospitals
- Clinics
- Fertility Centers
- Research Institutes
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Infertility Diagnosis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Infertility diagnosis is the process of determining if a couple is unable to conceive a child.
Some of the major players in the infertility diagnosis market are Merck, Procter & Gamble, BioMerieux, Abbott, Babystart, BioZhena Corporation, Quidel Corporation, SPD Swiss Precision Diagnostics GmbH, SCSA Diagnostics, Pride Angel.
The infertility diagnosis market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Infertility Diagnosis Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Infertility Diagnosis Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Infertility Diagnosis Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Infertility Diagnosis Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Infertility Diagnosis Market Size & Forecast, 2020-2028
4.5.1 Infertility Diagnosis Market Size and Y-o-Y Growth
4.5.2 Infertility Diagnosis Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Female Infertility Testing
5.2.2 Male Infertility Testing
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.2.3 Fertility Centers
6.2.4 Research Institutes
6.2.5 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Infertility Diagnosis Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Infertility Diagnosis Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Female Infertility Testing
9.6.2 Male Infertility Testing
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.10.3 Fertility Centers
9.10.4 Research Institutes
9.10.5 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Female Infertility Testing
10.6.2 Male Infertility Testing
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.10.3 Fertility Centers
10.10.4 Research Institutes
10.10.5 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Female Infertility Testing
11.6.2 Male Infertility Testing
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.10.3 Fertility Centers
11.10.4 Research Institutes
11.10.5 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Female Infertility Testing
12.6.2 Male Infertility Testing
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.10.3 Fertility Centers
12.10.4 Research Institutes
12.10.5 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Female Infertility Testing
13.6.2 Male Infertility Testing
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.10.3 Fertility Centers
13.10.4 Research Institutes
13.10.5 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Infertility Diagnosis Market: Competitive Dashboard
14.2 Global Infertility Diagnosis Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Merck
14.3.2 Procter & Gamble
14.3.3 BioMerieux
14.3.4 Abbott
14.3.5 Babystart
14.3.6 BioZhena Corporation
14.3.7 Quidel Corporation
14.3.8 SPD Swiss Precision Diagnostics GmbH
14.3.9 SCSA Diagnostics
14.3.10 Pride Angel
